We should see the following by then, at least:
- final results (actually within a week or two) making global news
- more prescribers added to the network and ramping up of sales under TGA early access (though sales will still be limited given it's still not the same as full approval market penetration)
- FDA and TGA pre approval meetings update
- announcement of further indication for trial
That being said, and at the current rate, may be $2.50 or less? No idea. Actually easier in some respects to place predictions for around late 2025 given 2025 is the major catalyst year.
We should see the following by then, at least:- final results...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.005(1.82%) |
Mkt cap ! $31.34M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.3¢ | 27.5¢ | $86.44K | 308.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 77717 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 50000 | 2 |
View Market Depth
| Last trade - 15.59pm 19/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |